Last reviewed · How we verify
serodiagnosis — Competitive Intelligence Brief
phase 1
Other
Biologic
Live · refreshed every 30 min
Target snapshot
serodiagnosis (serodiagnosis) — Centre Hospitalier Universitaire, Amiens.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| serodiagnosis TARGET | serodiagnosis | Centre Hospitalier Universitaire, Amiens | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- serodiagnosis CI watch — RSS
- serodiagnosis CI watch — Atom
- serodiagnosis CI watch — JSON
- serodiagnosis alone — RSS
Cite this brief
Drug Landscape (2026). serodiagnosis — Competitive Intelligence Brief. https://druglandscape.com/ci/serodiagnosis. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing